New Clinical Trial – Modified Citrus Pectin Halts Prostate Cancer Progression

Published: September 7, 2018 | By Better Health Publishing

A new double-blind clinical trial on modified citrus pectin (MCP) against biochemically
relapsed prostate cancer is opening new doors in the treatment of this aggressive
disease.

Download the full article (pdf)